These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 6339650

  • 1. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs.
    Murayama K, Kasai H, Adachi T, Utsunomiya O, Ouchi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650
    [Abstract] [Full Text] [Related]

  • 2. The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
    Hirano T, Nakafusa Y, Kawano R, Motoyama K, Arima T, Sugitani A, Tanaka M.
    Surgery; 2001 May; 129(5):595-605. PubMed ID: 11331452
    [Abstract] [Full Text] [Related]

  • 3. Cardioprotective actions of a selective thromboxane synthetase inhibitor in acute myocardial ischemia.
    Burke SE, Lefer DJ, Lefer AM.
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):76-84. PubMed ID: 6686001
    [Abstract] [Full Text] [Related]

  • 4. Stimulation of vessel wall prostacyclin by selective thromboxane synthetase inhibitor OKY 1581.
    Mehta J, Mehta P, Ostrowski N.
    Prostaglandins Leukot Med; 1983 Sep; 12(1):49-52. PubMed ID: 6356153
    [Abstract] [Full Text] [Related]

  • 5. The role of thromboxane A2 (TxA2) in allergic cutaneous reactions and the effect of (E)-3-[p-(1H-imidazol-1-ylmethyl) phenyl]-2-propenoic acid hydrochloride (OKY-046), a TxA2 synthetase inhibitor.
    Nagai H, Yakuo I, Nakatomi I, Inagaki N, Koda A.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Mar; 35(3):125-30. PubMed ID: 2710796
    [Abstract] [Full Text] [Related]

  • 6. Effects of thromboxane synthetase inhibitors on cyclical reduction of coronary blood flow in dogs.
    Uchida Y, Murao S.
    Jpn Heart J; 1981 Nov; 22(6):971-5. PubMed ID: 7040725
    [Abstract] [Full Text] [Related]

  • 7. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
    Morimoto K, Ikata T, Tounai T.
    Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological studies on the TXA2 synthetase inhibitor (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046).
    Hiraku S, Taniguchi K, Wakitani K, Omawari N, Kira H, Miyamoto T, Okegawa T, Kawasaki A, Ujiie A.
    Jpn J Pharmacol; 1986 Jul; 41(3):393-401. PubMed ID: 3093741
    [Abstract] [Full Text] [Related]

  • 9. Effects of a thromboxane A2-receptor antagonist, a thromboxane synthetase inhibitor and aspirin on prostaglandin I2 production in endothelium-intact and -injured aorta of guinea pigs.
    Higo K, Karasawa A.
    Jpn J Pharmacol; 1994 Dec; 66(4):471-9. PubMed ID: 7723224
    [Abstract] [Full Text] [Related]

  • 10. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
    Casey LC, Fletcher JR, Zmudka MI, Ramwell PW.
    J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
    [Abstract] [Full Text] [Related]

  • 11. Effects of a thromboxane synthetase inhibitor (OKY-046) on vascular reactivity to angiotensin II after stricture of the abdominal aorta in pregnant rabbits.
    Ushijima H, Ito M, Yoshimura T, Mabe K, Okamura H.
    Artery; 1992 Aug; 19(2):63-75. PubMed ID: 1580798
    [Abstract] [Full Text] [Related]

  • 12. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y, Hattori R, Takatsu Y, Nakajima H, Wakabayashi A, Kawai C, Kayama N, Hiraku S, Inagawa T, Tsubojima M.
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.
    Hiraku S, Wakitani K, Katsube N, Kawasaki A, Tsuboshima M, Naito J, Ujiie A, Komatsu H, Iizuka K.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Oct; 11():241-4. PubMed ID: 6221530
    [No Abstract] [Full Text] [Related]

  • 14. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
    Aiken JW, Shebuski RJ, Miller OV, Gorman RR.
    J Pharmacol Exp Ther; 1981 Nov; 219(2):299-308. PubMed ID: 6270303
    [No Abstract] [Full Text] [Related]

  • 15. Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046.
    Hatziantoniou C, Papanikolaou N.
    Experientia; 1986 Jun 15; 42(6):613-5. PubMed ID: 3522267
    [Abstract] [Full Text] [Related]

  • 16. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep.
    Kubo K, Kobayashi T.
    Am Rev Respir Dis; 1985 Sep 15; 132(3):494-9. PubMed ID: 3898941
    [Abstract] [Full Text] [Related]

  • 17. Prostacyclin and thromboxane in cerebral vasospasm II: Effects of thromboxane synthetase inhibitor (OKY-1581) on experimentally-induced cerebral vasospasm.
    Yabuno N.
    Acta Med Okayama; 1984 Jun 15; 38(3):239-50. PubMed ID: 6380217
    [Abstract] [Full Text] [Related]

  • 18. In vivo enhancement of platelet activating factor-induced prostacyclin production by OKY-046, a selective inhibitor of thromboxane A2 synthase.
    Davenport NJ, Goldstein RE, Feuerstein GZ.
    J Cardiovasc Pharmacol; 1991 Apr 15; 17(4):641-6. PubMed ID: 1711633
    [Abstract] [Full Text] [Related]

  • 19. [Thromboxane A2 synthetase inhibitor in asthma therapy].
    Machida K, Takagi K, Horiba M.
    Nihon Rinsho; 1996 Nov 15; 54(11):3034-9. PubMed ID: 8950950
    [Abstract] [Full Text] [Related]

  • 20. Effects of thromboxane synthase inhibitors on renal function.
    Jackson EK, Goto F, Uderman HD, Workman RJ, Herzer WA, FitzGerald GA, Branch RA.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb 15; 337(2):183-90. PubMed ID: 3285227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.